{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:51:51Z","timestamp":1771663911504,"version":"3.50.1"},"reference-count":30,"publisher":"Informa Healthcare","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2012,7,1]]},"DOI":"10.1185\/03007995.2012.689254","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T08:42:52Z","timestamp":1335516172000},"page":"1119-1127","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of the clinical benefit of long-term (beyond 2 years) treatment of skeletal-related events in advanced cancers with zoledronic acid"],"prefix":"10.1185","volume":"28","author":[{"given":"Henry","family":"Henk","sequence":"first","affiliation":[{"name":"OptumInsight, Eden Prairie, MNUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April","family":"Teitelbaum","sequence":"additional","affiliation":[{"name":"OptumInsight, San Diego, CAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyin","family":"Kaura","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, Florham Park, NJ, USA (during preparation of this manuscript)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2012,5,17]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0931"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi122"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.3816\/SCT.2005.n.017"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1080\/02841860802167490"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22991"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2007.03.013"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2010.10.015"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm442"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.5.9.3305"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11701"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20308"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh141"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.08.017"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn796"},{"key":"CIT0015","unstructured":"Zometa (zoledronic acid) injection [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation, 2011"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2009.0076"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.5209"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.116"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.535511"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23775"},{"key":"CIT0021","unstructured":"Body J-J, Cook R, Costa L, et al. Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumors and poor prognostic features. In: Proceedings of the IX International Meeting on Cancer Induced Bone Disease; 2009 Oct 28-31. Poster 71"},{"key":"CIT0022","unstructured":"Costa L, Cook R, Body J-J, et al. Zoledronic acid treatment delays disease progression and improves survival in patients with bone metastases from solid tumors and elevated levels of bone resorption. In: Proceedings of the IX International Meeting on Cancer Induced Bone Disease; 2009 Oct 28-31. Poster 50"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62051-X"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1159\/000093006"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-006-9025-y"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24756"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605604"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P152"},{"key":"CIT0029","first-page":"377","volume":"7","author":"Rosen LS","year":"2001","journal-title":"Cancer J"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-010-1067-7"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/03007995.2012.689254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T04:28:07Z","timestamp":1597552087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/03007995.2012.689254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,17]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7,1]]}},"alternative-id":["10.1185\/03007995.2012.689254"],"URL":"https:\/\/doi.org\/10.1185\/03007995.2012.689254","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,17]]}}}